1. Department of Medicine II, Department for Hematology/Oncology, Goethe University, Frankfurt, Germany;
2. German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany;
3. Molecular Therapy in Haematology and Oncology and Department of Translational Oncology, NCT and DKFZ, Heidelberg, Germany;
4. Division of Pre-Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Rockville, MD;
5. enGene Statistics GmbH, Basel, Switzerland;
6. Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD;
7. Division of Hematology/Oncology, Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA;
8. Frankfurt Cancer Institute, Goethe University Frankfurt, Frankfurt, Germany;
9. Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany;
10. Department of Hematology and Oncology, Georg August University, Göttingen, Germany;
11. Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland;
12. Whitehead Institute for Biomedical Research, Cambridge, MA;
13. Institute of Cellular and Molecular Immunology, Georg August University of Göttingen, Göttingen, Germany;
14. Lewis-Sigler Institute for Integrative Genomics,
15. Department of Chemistry, and
16. Princeton University Small Molecule Screening Center, Princeton University, Princeton, NJ;
17. Institute for Pathology, Molecular Cytology and Functional Genomics, University Hospital Giessen, Giessen, Germany;
18. Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK;
19. Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany;
20. Bioanalytics, Georg August University, Göttingen, Germany;
21. Charité-University Medical Center, Department of Hematology, Oncology and Tumor Immunology, Virchow Campus, and Molekulares Krebsforschungszentrum, Berlin, Germany;
22. Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany;
23. Department of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria;
24. Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, and
25. Center for Integrated Oncology, University of Cologne, Cologne, Germany;
26. Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany;
27. Koch Institute for Cancer Research at MIT, Cambridge, MA;
28. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and
29. Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland